isabelobrien, Author at European Medical Journal - Page 60 of 70

Let's talk about sexual health

What role can medical affairs professionals play in filling this knowledge gap as they communicate the importance of sexual health?

Is pharma ready to stop cyber attacks in their tracks?

Cyber-attacks have become a mounting threat to the pharmaceutical industry over the past year, putting COVID-19 research data as well as supply and distribution chains at risk. We explore what can pharma learn from more experienced industries as they try to mitigate hacking

Abbott Vascular’s Nick West on powering up personalised care

Dr Nick West, Chief Medical Officer, Abbott Vascular, shares with GOLD his hopes for the future of personalised care, enhancing patient centricity worldwide and the upskilling potential of virtual reality.

Talking to Uzair Qadeer

Uzair Qadeer, Chief Diversity Officer, Alexion, discusses his notable career as an HR futurist, plus diversity and belonging in pharma.

Talking to Kevin O'Brien

Kevin O’Brien, President, North America, Merz Therapeutics, talks about the intricacies of developing a treatment for a new indication.

Talking to Ester Banque

Ester Banque, Senior Vice President and Head of Intercontinental Commercial, BMS, talks about her unique approach to leadership.

Mind the pay gap

The gender pay gap is far from solved, how companies can address the imbalance head-on?

Talking to Kay Wesley

Kay Wesley, Chief Executive, Kanga Health, talks about pharma’s digital transformation and her passion for creating gender equality.

Talking to Nancy Globus

Nancy Globus, Vice President for Regulatory and Medicine Safety, Addison Whitney, talks medication safety, product labelling and errors.

The 2021 pharma forecast

Looking forward to the year ahead, GOLD casts five predictions for what the standout advancements and priorities will be for pharma in 2021.